Lonza Pharma & Biotech

As one of the world’s most renowned companies for contract development and manufacturing, Lonza is recognized for high-quality service, global capacity, innovative technology platforms, and extensive experience.

Their most recent project coming to it's exciting final phase is the Cocoon® Platform, the next level in closed and automated cell processing. The Cocoon® Platform streamlines patient-scale cell therapy manufacturing for greater efficiency and reliability.

Automated, closed and flexible, this end-to-end cell manufacturing platform gives you increased control over your specific process.

Highly customizable and scalable, the Cocoon® Platform is an integrated turnkey solution ready to use off-the-shelf. Designed to save time and lower costs, Cocoon® enables you to quickly and efficiently advance your project from pre-clinical through commercial-scale manufacturing.

Electromate has worked closely with Lonza for the past nine years to get the platform from its initial concept to its final stage. The system utilizes a peristaltic pump gearmotor with controller module, and tilt gearmotors with a servo-amplifier module for the cocoon door. It also has a brushed gearmotor for the magnetic separation in the cocoon.